Presentations
POSTER
Clofutriben inhibits 11β-hydroxysteroid dehydrogenase type 1 and improves ACTH-dependent Cushing’s syndrome compared to placebo in a Phase II trial (RESCUE)
POSTER
Hypothalamic-Pituitary-Adrenal Axis Suppression by Prednisolone Reversed by the 11β-Hydroxysteroid Dehydrogenase Type 1 (HSD-1) Inhibitor Clofutriben
POSTER
Clofutriben to Improve the Benefit-Risk Profile of Prednisolone in Patients with Polymyalgia Rheumatica
POSTER
Controlling intracellular cortisol: Can HSD-1 inhibition reduce Cushing’s syndrome morbidity and minimize adrenal insufficiency risk?
POSTER
HPA axis modulation by a potent inhibitor indicates 11β-hydroxysteroid dehydrogenase type 1 (HSD-1) is a significant contributor to cortisol levels
POSTER
The “RESCUE” Trial: 11β-Hydroxysteroid Dehydrogenase Type 1 (HSD-1) Inhibition
for ACTH-Dependent Cushing’s Syndrome
POSTER